openPR Logo
Press release

Biopharmaceutical Logistics Market to Expand at a CAGR of 6.2% from 2016 to 2024

09-14-2017 08:27 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Biopharmaceutical Logistics Market to Expand at a CAGR of 6.2%

Several leading players are actively investing in constructing new logistics facilities in various emerging nations to consolidate their regional presence. Furthermore, numerous players are providing user-friendly shipping and transportation, visibility tools, and a variety of specialized e-commerce and logistics management services in order to gain a better foothold in the market. The global biopharmaceutical logistics market is expected to expand at a CAGR of 6.2% from 2016 to 2024. The market was valued at US$70.9 bn and is projected to surge to reach US$120.7 bn by the end of the forecast period.

Tightening Regulations on Transportation of Temperature-Sensitive Pharmaceutical Products

The soaring demand for temperature-controlled logistics for the transportation of biopharmaceuticals in various regions and the need for safe transportation of these products are the key factors driving the market. A large number of biopharmaceutical companies seek the services of companies who ensure the transportation of their products in conformity with international standards. Furthermore, in-depth understanding of specific custom clearance regulations and operating procedures is imperative for hassle-free transportation of these goods. This is a crucial factor boosting the market. The growing number of global biopharmaceutical players are conducting clinical trials in emerging nations or have to go for shipments in difficult zones. This is a key factor catalyzing the growth of the biopharmaceutical logistics market.

View and Download TOC of Biopharmaceutical Logistics Market Research Report @ http://www.transparencymarketresearch.com/report-toc/23858

Advanced Packaging and Refrigeration Technologies to Accentuate Market Growth

The pressing demand among biopharmaceutical and biotechnology companies to improve their supply chains and minimize temperature excursions has boosted the market. The advent of advanced packaging and refrigeration technology has led many logistics companies to ensure better transportation of goods. The adoption of these technologies enable biopharmaceutical companies to gain a better visibility of their shipments, which helps them minimize or prevent any transportation loss. The substantial production of biological drugs has also increased the transportation of biopharmaceuticals.

Compared to sea transportation, the high cost associated with the transportation of highly temperature sensitive biopharmaceuticals has dissuaded many biotech and pharmaceutical companies to avail these services. This has impeded the growth of the market to an extent. Nevertheless, the bourgeoning production of targeted therapies and drugs in the medical sector is expected to open up numerous exciting opportunities for market players. In addition, the advent of cutting-edge solutions to improve critical supply of clinical trials is also expected to boost the biopharmaceutical logistics market.

Request and Download Sample Report@ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23858

Sea Shipping and Road Shipping Segments to Garner Major Volume Share

Geographically, the global biopharmaceutical logistics market is led by Europe and North America. The growth of these regional markets is fueled by the large number of exports and imports of biopharmaceutical products and constant technological advancements to improve transportation services and warehousing facilities.

Based on mode of transportation, the market can be segmented into sea shipping, air shipping, rail shipping, and road shipping. Of these, air shipping is projected to dominate the biopharmaceutical logistics market, when valued in terms of revenue. However, owing to the limited volumes of transportation possible with air shipping, sea shipping and road shipping are projected to gain traction. These segments are anticipated to occupy the major volume share during the forecast period.

The biopharmaceutical logistics market features a fairly competitive landscape characterized by moderate-to-high degree of competition among the players, observes Transparency Market Research (TMR). The competition in the market landscape is likely to remain unchanged over the forecast period from 2016 to 2024. However, the intensity of competition may subside to an extent, owing to prominent players exploring innovative logistics services pertaining to specific regions, The leading five companies held a combined a market share of 31.0% in 2015, notes TMR. These players are DHL Express, FedEx Corporation, United Parcel Service, DB Schenker, and AmerisourceBergen Corporation.

Buy Full Biopharmaceutical Logistics Market Report@ http://www.transparencymarketresearch.com/checkout.php?rep_id=23858<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Logistics Market to Expand at a CAGR of 6.2% from 2016 to 2024 here

News-ID: 715696 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Biopharmaceutical

Global Biopharmaceutical Stability Testing Market
According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is projected to grow from USD 3.2 billion in 2022 to USD 10.8 billion in 2027 at a CAGR of 13.3% from 2022 to 2027. Intertek Group plc, Eurofins Scientific, Pacific Biolabs, SGS SA, Element Materials Technology, Almac Group, Merck KGaA, Catalent, Inc., Pace Analytical Life Sciences, Boston Analytical, Kemwell Biopharma, Curia Global,
Biopharmaceutical Testing Services Market 2021 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Biopharmaceutical Testing Services market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players’ performance based on revenue generation and client requirements. Also, the research report reveals
BioPharmaceutical Tubing Market 2021 | Detailed Report
According to Market Study Report, BioPharmaceutical Tubing Market provides a comprehensive analysis of the BioPharmaceutical Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of BioPharmaceutical Tubing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024225 The report provides a comprehensive analysis of
Biopharmaceutical Market - Massive Growth opportunity Ahead
A new research document with title 'State of the Biopharmaceutical Industry 2021' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors. The report will help user gain market insights, future trends and growth prospects for forecast period of 2021 Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/3060794-state-of-the-biopharmaceutical-industry Summary 2021 promises to be a year of continued innovation and change in the
Biopharmaceutical Logistics Market Is Thriving Worldwide |
The Biopharmaceutical Logistics Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Biopharmaceutical Logistics market report provides authentic and reliable estimates for the forecast period. It became essential to distinguish the saturation of consumption in the Biopharmaceutical Logistics market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation
The Future Of Investing: Biopharmaceutical Logistics Market
The pharmaceutical industry is dynamic and is likely to experience high growth in the coming years. Today, growing sales of drugs and biologics, changing dynamics of the pharmaceutical industry, and stringent regulatory controls are some of the factors boosting the demand for pharmaceutical logistics services.  Outsourcing logistics operations are trending in the pharma industry for cost optimization and technology advancement. Pharmaceutical companies are facing tremendous pressure for cutting down the cost of